임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

41건 표시

1상모집 중· Healthy Participants
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Enicepatide in Generally Healthy Adult Chinese Participants
리드: 로슈
상세 →NCT07626515
1상모집 중· Osteosarcoma
Atezolizumab in Combination With Stereotactic Body Radiation Therapy (SBRT) and Surgery for Relapsed Osteosarcoma
협력: 로슈
상세 →NCT06492954
1상모집 중· Active Ulcerative Colitis
An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
리드: 로슈
상세 →NCT07665723
1상모집 중· Relapsed/Refractory Multiple Myeloma
A Study to Evaluate RO7851624 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)
리드: 로슈
상세 →NCT07558915
1상모집 중· Diabetic Retinopathy
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of RO7663498 Following Intravitreal Administration in Participants With Diabetic Retinopathy
리드: 로슈
상세 →NCT07588100
1상모집 중· Diabetic Macular Edema
A Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of RO7823653 in Participants With Diabetic Macular Edema (DME)
리드: 로슈
상세 →NCT07425522
1상모집 중· Stable Coronary Artery Disease
A Study to See How RO7763505 Works and How Safe it is When Given to Healthy People and People With Stable Heart Disease
리드: 로슈
상세 →NCT07495813
1상모집 중· Healthy Volunteers
A Study of Multiple Doses of Orally Administered RO7795081 in Otherwise Healthy Chinese Adult Participants With Obesity or Overweight
리드: 로슈
상세 →NCT07499050
1상모집 중· Healthy Volunteers
A Dose-Escalation Study of RO7875913 in Healthy Participants
리드: 로슈
상세 →NCT07342114
1상모집 중· Alzheimer's Disease
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
리드: 로슈
상세 →NCT07234942
1상모집 중· Extensive Stage Small Cell Lung Cancer (ES-SCLC)
Iadademstat + SBRT With Atezo in ES-SCLC
협력: 로슈
상세 →NCT07113691
1상모집 중· Breast Cancer
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-0587 as a Monotherapy and in Combination With Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive and Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer
리드: 로슈
상세 →NCT07214662
1상모집 중· Healthy Volunteers
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7806881 in Healthy Participants
리드: 로슈
상세 →NCT07271693
1상모집 중· Huntington's Disease
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RG6496 in Huntington's Disease
리드: 로슈
상세 →NCT07246941
1상모집 중· Hepatic Impairment
A Study to Evaluate the Effect of Moderate or Severe Hepatic Impairment on the Pharmacokinetics (PK) of Inavolisib
리드: 로슈
상세 →NCT07144111
1상모집 중· Anaplastic Lymphoma Kinase
A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive Anaplastic Large Cell Lymphoma (ALK+ALCL)
협력: 로슈
상세 →NCT07001384
1상모집 중· Overweight
A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants
리드: 로슈
상세 →NCT06982131
1상모집 중· Acute Myeloid Leukemia Refractory
A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia
협력: 로슈
상세 →NCT07011004
1상모집 중· Multiple Myeloma
A Study Evaluating the Pharmacokinetics, Safety, and Efficacy of Cevostamab in Chinese Participants With Relapsed or Refractory Multiple Myeloma
리드: 로슈
상세 →NCT06934044
1상모집 중· Neoplasms
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Clinical Activity of RO7673396 in Participants With Advanced Solid Tumors Harboring Rat Sarcoma Viral Oncogene Homolog (RAS) Mutation(s)
리드: 로슈
상세 →NCT06884618
1상모집 중· Lymphoma
A Study Evaluating the Safety and Efficacy of Glofitamab + Gemcitabine + Oxaliplatin in U.S. Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
리드: 로슈
상세 →NCT06624085
1상모집 중· Solid Tumors
A Study of HS-20110 in Participants With Advanced Solid Tumors
협력: 로슈
상세 →NCT06892379
1상모집 중· Metastatic Lung Non-Small Cell Carcinoma
Vismodegib and Atezolizumab for the Treatment of Recurrent or Metastatic Non-Small Cell Lung Cancer
협력: 로슈
상세 →NCT06616623
1상모집 중· Multiple Sclerosis
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of a New Subcutaneous Formulation of Ocrelizumab in Participants With Multiple Sclerosis
리드: 로슈
상세 →NCT07667322
1상모집 중· Non-cystic Fibrosis Bronchiectasis
A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
리드: 로슈
상세 →NCT06603246
1상모집 중· Solid Tumor
A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors
리드: 로슈
상세 →NCT06619587
1상모집 중· Advanced Solid Tumors
Safety,Tolerability, Pharmacokinetics, and Efficacy of YL211 in Patients With Advanced Solid Tumors
협력: 로슈
상세 →NCT06384352
1상모집 중· Locally Advanced Solid Tumors
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
리드: 로슈
상세 →NCT06031441
1상모집 중· Endometrial Cancer
ONC201 and Atezolizumab in Obesity-Driven Endometrial Cancer
협력: 로슈
상세 →NCT05542407
1상모집 중· Relapsed or Refractory Multiple Myeloma
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
리드: 로슈
상세 →NCT05927571
1상모집 중· Advanced Prostate Cancer
A Study Evaluating the Safety, Pharmacokinetics, and Activity of RO7656594 In Participants With Advanced or Metastatic Prostate Cancer
리드: 로슈
상세 →NCT05800665
1상모집 중· Von Willebrand Disease, Type 3
Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
협력: 로슈
상세 →NCT05500807
1상모집 중· Non-Hodgkin Lymphoma
A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Mosunetuzumab or Glofitamab in Combination With CC-220 and/or CC-99282 in Participants With B-Cell Non-Hodgkin Lymphoma
리드: 로슈
상세 →NCT05169515
1상모집 중· Locally Advanced or Metastatic Solid Tumors
A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors
리드: 로슈
상세 →NCT05581004
1상모집 중· Unresectable Hepatocellular Carcinoma
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
협력: 로슈
상세 →NCT05096715
1상모집 중· Locally Advanced Skin Squamous Cell Carcinoma
Radiotherapy in Combination With Atezolizumab in Locally Advanced Borderline Resectable or Unresectable Cutaneous SCC
협력: 로슈
상세 →NCT05085496
1상모집 중· Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia
리드: 로슈
상세 →NCT05091424
1상모집 중· Metastatic Colorectal Cancer
A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)
리드: 로슈
상세 →NCT04929223
1상모집 중· Multiple Sclerosis
A Study to Investigate the Safety, Tolerability, and Processing by the Body of Intravenous and Subcutaneous RO7121932 Administration in Participants With Multiple Sclerosis
리드: 로슈
상세 →NCT05704361
1상모집 중· Duchenne Muscular Dystrophy
A Gene Transfer Therapy Study to Evaluate the Safety of and Expression From Delandistrogene Moxeparvovec (SRP-9001) in Participants With Duchenne Muscular Dystrophy (DMD) - Non-Ambulatory Cohort
협력: 로슈
상세 →NCT04626674
1상모집 중· Aggressive Non-Hodgkin Lymphoma
Polatuzumab Vedotin and Combination Chemotherapy With or Without Glofitamab for the Treatment of Untreated Aggressive Large B-cell Lymphoma
협력: 로슈
상세 →NCT04231877

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.